Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at treatment for high risk chronic lymphocytic leukaemia (CLL 210)

Overview

Cancer types:

Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia

Status:

Results

Phase:

Phase 2

Details

This trial was for people with chronic lymphocytic leukaemia (CLL) who had a high risk of their leukaemia coming back.

Cancer Research UK supported this trial.

Recruitment start: 6 February 2012

Recruitment end: 31 October 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof A Pettitt

Supported by

Baxter Ltd

Cancer Research UK

Cancer Research UK Liverpool Cancer Trials Unit (LCTU)

Celgene Ltd

Chugai Pharmaceutical Co Ltd

GlaxoSmithKline (GSK)

NIHR Clinical Research Network: Cancer

Royal Liverpool and Broadgreen University Hospital NHS Trust

University of Liverpool

Other information

This is Cancer Research UK trial number CRUKE/09/035.

Last reviewed: 20 Sept 2017

CRUK internal database number: 3492

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.